SERIES B COMMON STOCK PURCHASE WARRANT oculus innovative sciences, inc.Warrant Agreement • February 26th, 2014 • Oculus Innovative Sciences, Inc. • Surgical & medical instruments & apparatus
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after August 26, 2014 (the “Initial Exercise Date”) and on or prior to the close of business on the later of (a) one (1) year from the earlier of (i) the effective date of an effective registration statement pursuant to which all the Warrant Shares are registered for resale and (ii) the date that all Warrant Shares may be sold by the Holder pursuant to Rule 144 (without volume limitations and assuming cashless exercise) and (b) one (1) year anniversary of the closing of the Ruthigen IPO, provided that in any event this Warrant shall be exercisable for at least a full year (the “Termination Date”), but not thereafter, to subscribe for and purchase from Oculus Innovative Sciences, Inc., a Delaware corporation (the “Company”), up t
SERIES A COMMON STOCK PURCHASE WARRANT oculus innovative sciences, inc.Common Stock Purchase Warrant • February 26th, 2014 • Oculus Innovative Sciences, Inc. • Surgical & medical instruments & apparatus
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after February 26, 2014 (the “Initial Exercise Date”) and on or prior to the close of business on February 26, 2019 (the “Termination Date”), but not thereafter, to subscribe for and purchase from Oculus Innovative Sciences, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • February 26th, 2014 • Oculus Innovative Sciences, Inc. • Surgical & medical instruments & apparatus • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of February 21, 2014, between Oculus Innovative Sciences, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
COMMON STOCK PURCHASE WARRANT oculus innovative sciences, inc.Common Stock Purchase Warrant • February 26th, 2014 • Oculus Innovative Sciences, Inc. • Surgical & medical instruments & apparatus
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, Dawson James Securities, Inc. or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after February 26, 2014 (the “Initial Exercise Date”) and on or prior to the close of business on May 3, 2016 (the “Termination Date”), but not thereafter, to subscribe for and purchase from Oculus Innovative Sciences, Inc., a Delaware corporation (the “Company”), up to 69,037 shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is issued by the Company as of the date hereof pursuant to Section A.2 of the Engagement Letter entered into by and between the Company and Dawson James Securities, Inc., dated as of February 21, 2014.
